Healthcare provider profile · identity verified

Lorieva Acevedo, MD

Allopathic & Osteopathic Physicians|General Practice · PONCE, PR · NPI 1245270560

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Lorieva Acevedo, MD received $63.70 in general payments during 2025 across 3 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 37.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Jardiance.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 68 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Symbicort by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Jardiance by this doctor in 2024.

E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$63.70

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$23.54	37.0%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$20.90	32.8%	1	2025
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$19.26	30.2%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$63.70	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$23.54	1	2025
Source payment records 2025-09-22 · Boehringer Ingelheim Pharmaceuticals, Inc. · $23.54 · Open Payments source
AIRSUPRA Normalized: airsupra	Drug	AstraZeneca Pharmaceuticals LP	$20.90	1	2025
Source payment records 2025-03-12 · AstraZeneca Pharmaceuticals LP · $20.90 · Open Payments source
ELIQUIS Normalized: eliquis	Drug	E.R. Squibb & Sons, L.L.C.	$19.26	1	2025
Source payment records 2025-03-05 · E.R. Squibb & Sons, L.L.C. · $19.26 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	72	exact normalized	Medicare Part D
JARDIANCE jardiance	2025	Jardiance	2024	30 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	23	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	68	15
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS
E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713	Eliquis · 2024 Exact normalized brand match · 1 Part D row	72	12

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	956	263
Famotidine	Famotidine	828	209
Gabapentin	Gabapentin	651	145
Levothyroxine Sodium	Levothyroxine Sodium	618	139
Losartan Potassium	Losartan Potassium	484	139
Simvastatin	Simvastatin	468	128
Lisinopril	Lisinopril	430	116
Omeprazole	Omeprazole	428	94
Temazepam	Temazepam	372	67
Metformin Hcl	Metformin Hcl	371	101
Baclofen	Baclofen	370	96
Buspirone Hcl	Buspirone Hcl	353	82
Pantoprazole Sodium	Pantoprazole Sodium	292	75
Clopidogrel	Clopidogrel Bisulfate	282	64
Synthroid	Levothyroxine Sodium	281	60
Amlodipine Besylate	Amlodipine Besylate	268	81
Clonazepam	Clonazepam	252	39
Tamsulosin Hcl	Tamsulosin Hcl	232	66
Carvedilol	Carvedilol	211	62
Donepezil Hcl	Donepezil Hcl	209	55
Hydrochlorothiazide	Hydrochlorothiazide	208	73
Furosemide	Furosemide	203	69
Alendronate Sodium	Alendronate Sodium	202	42
Metoprolol Tartrate	Metoprolol Tartrate	202	47
Metoprolol Succinate	Metoprolol Succinate	200	63
Memantine Hcl	Memantine Hcl	188	54
Alprazolam	Alprazolam	179	31
Glipizide	Glipizide	176	59
Diclofenac Sodium	Diclofenac Sodium	175	59
Sertraline Hcl	Sertraline Hcl	166	43
Montelukast Sodium	Montelukast Sodium	162	39
Trazodone Hcl	Trazodone Hcl	140	37
Latanoprost	Latanoprost	138	22
Lorazepam	Lorazepam	137	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	131	64
Isosorbide Mononitrate Er	Isosorbide Mononitrate	124	29
Lantus	Insulin Glargine,hum.Rec.Anlog	123	24
Rosuvastatin Calcium	Rosuvastatin Calcium	123	41
Ezetimibe	Ezetimibe	116	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	26
Lansoprazole	Lansoprazole	101	23
Escitalopram Oxalate	Escitalopram Oxalate	95	21
Atenolol	Atenolol	92	27
Mirtazapine	Mirtazapine	89	16
Albuterol Sulfate Hfa	Albuterol Sulfate	86	24
Citalopram Hbr	Citalopram Hydrobromide	86	11
Fluoxetine Hcl	Fluoxetine Hcl	86	15
Fenofibrate	Fenofibrate	83	27
Finasteride	Finasteride	81	28
Oxybutynin Chloride Er	Oxybutynin Chloride	77	17
Levetiracetam	Levetiracetam	75	12
Glimepiride	Glimepiride	73	24
Allopurinol	Allopurinol	72	21
Eliquis	Apixaban	72	12
Nifedipine Er	Nifedipine	72	21
Fluticasone Propionate	Fluticasone Propionate	71	27
Pravastatin Sodium	Pravastatin Sodium	70	22
Pregabalin	Pregabalin	70	suppressed
Farxiga	Dapagliflozin Propanediol	68	15
Quetiapine Fumarate	Quetiapine Fumarate	68	12
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	67	suppressed
Meloxicam	Meloxicam	67	25
Azithromycin	Azithromycin	63	45
Dexamethasone	Dexamethasone	62	49
Nabumetone	Nabumetone	62	28
Warfarin Sodium	Warfarin Sodium	59	suppressed
Enalapril Maleate	Enalapril Maleate	58	21
Meclizine Hcl	Meclizine Hcl	58	26
Humalog	Insulin Lispro	57	suppressed
Prednisone	Prednisone	57	23
Phenytoin Sodium Extended	Phenytoin Sodium Extended	56	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	53	11
Doxazosin Mesylate	Doxazosin Mesylate	50	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	44
Hydralazine Hcl	Hydralazine Hcl	46	16
Janumet	Sitagliptin Phos/Metformin Hcl	46	suppressed
Spironolactone	Spironolactone	46	17
Verapamil Er	Verapamil Hcl	46	suppressed
Cimetidine	Cimetidine	45	15
Risperidone	Risperidone	45	11
Insulin Syringe	Syringe And Needle,insulin,1ml	44	12
Levofloxacin	Levofloxacin	43	40
Ondansetron Hcl	Ondansetron Hcl	43	26
Xarelto	Rivaroxaban	43	11
Jentadueto	Linagliptin/Metformin Hcl	42	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	42	13
Irbesartan	Irbesartan	41	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	12
Sucralfate	Sucralfate	40	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	40	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	39	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	38	22
Cilostazol	Cilostazol	37	13
Phenobarbital	Phenobarbital	37	suppressed
Potassium Chloride	Potassium Chloride	37	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	37	15
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Anastrozole	Anastrozole	34	suppressed
Ciclopirox	Ciclopirox	34	21
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Valsartan	Valsartan	33	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Sildenafil Citrate	Sildenafil Citrate	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	12
Diclofenac Potassium	Diclofenac Potassium	31	14
Fenofibrate	Fenofibrate Nanocrystallized	31	14
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Nitroglycerin	Nitroglycerin	30	15
Timolol Maleate	Timolol Maleate	30	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Lactulose	Lactulose	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Memantine Hcl Er	Memantine Hcl	28	suppressed
Tadalafil	Tadalafil	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	27	suppressed
Levoxyl	Levothyroxine Sodium	27	suppressed
Pentoxifylline	Pentoxifylline	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Theophylline Er	Theophylline Anhydrous	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Brilinta	Ticagrelor	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Naproxen	Naproxen	23	suppressed
Sulindac	Sulindac	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	14
Estazolam	Estazolam	21	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	21	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	21	18
Naproxen Sodium	Naproxen Sodium	21	12
Risedronate Sodium	Risedronate Sodium	21	suppressed
Ssd	Silver Sulfadiazine	21	15
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	20	17
Chlorthalidone	Chlorthalidone	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Tradjenta	Linagliptin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Cephalexin	Cephalexin	18	18
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Fluconazole	Fluconazole	18	18
Terazosin Hcl	Terazosin Hcl	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	11
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	16	15
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	16	suppressed
Etodolac	Etodolac	15	suppressed
Galantamine Er	Galantamine Hbr	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Pen Needle	Pen Needle, Diabetic	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Bicalutamide	Bicalutamide	13	suppressed
Emgality Pen	Galcanezumab-Gnlm	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	12	suppressed
Humalog Mix 50-50 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$63.70 · 3 records	Boehringer Ingelheim Pharmaceuticals, Inc.	AIRSUPRA, ELIQUIS, JARDIANCE	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error